Lorena Simón‐Gracia

3.0k total citations
36 papers, 1.2k citations indexed

About

Lorena Simón‐Gracia is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Lorena Simón‐Gracia has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Biomaterials and 10 papers in Oncology. Recurrent topics in Lorena Simón‐Gracia's work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (10 papers) and Immunotherapy and Immune Responses (6 papers). Lorena Simón‐Gracia is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (10 papers) and Immunotherapy and Immune Responses (6 papers). Lorena Simón‐Gracia collaborates with scholars based in Estonia, United States and Spain. Lorena Simón‐Gracia's co-authors include Tambet Teesalu, Pablo Scodeller, Venkata Ramana Kotamraju, Erkki Ruoslahti, Hedi Hunt, Giuseppe Battaglia, Kazuki N. Sugahara, Allan Tobi, Cyrus R. Safinya and Kai K. Ewert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Biomaterials.

In The Last Decade

Lorena Simón‐Gracia

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Lorena Simón‐Gracia

Since Specialization

Citations

This map shows the geographic impact of Lorena Simón‐Gracia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Simón‐Gracia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Simón‐Gracia more than expected).

Fields of papers citing papers by Lorena Simón‐Gracia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Simón‐Gracia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Simón‐Gracia. The network helps show where Lorena Simón‐Gracia may publish in the future.

Co-authorship network of co-authors of Lorena Simón‐Gracia

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Simón‐Gracia. A scholar is included among the top collaborators of Lorena Simón‐Gracia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Simón‐Gracia. Lorena Simón‐Gracia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy 2024 ·Scientific Reports ·(unknown), Pablo Scodeller, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuki N. Sugahara, Lorena Simón‐Gracia, Tambet Teesalu	3
2	Bi-functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma 2023 ·HPB ·Éric Savier, Pierre Tufféry, Lorena Simón‐Gracia, Séverine Loisel, Frédéric Charlotte, Tambet Teesalu, Olivier Scatton, Angelita Rebollo	1
3	Targeting of Tomato Bushy Stunt Virus with a Genetically Fused C-End Rule Peptide 2023 ·Nanomaterials ·(unknown), Lorena Simón‐Gracia, Chiara Lico, Mariateresa Mancuso, Selene Baschieri, Luca Santi, Tambet Teesalu	3
4	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1 2022 ·Proceedings of the National Academy of Sciences ·Boris Simonetti, James L. Daly, Lorena Simón‐Gracia, Katja Klein, Saroja Weeratunga, Carlos Antón-Plágaro, Allan Tobi, Lorna Hodgson, Philip A. Lewis, Kate J. Heesom, Deborah K. Shoemark, Andrew D. Davidson, Brett M. Collins, Tambet Teesalu, Yohei Yamauchi, Peter J. Cullen	18
5	Novel Anthracycline Utorubicin for Cancer Therapy 2021 ·Angewandte Chemie International Edition ·Lorena Simón‐Gracia, (unknown), (unknown), (unknown), (unknown), (unknown), Tambet Teesalu	11
6	Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma 2021 ·Pharmaceutics ·Éric Savier, Lorena Simón‐Gracia, Frédéric Charlotte, Pierre Tufféry, Tambet Teesalu, Olivier Scatton, Angelita Rebollo	8
7	Novel Anthracycline Utorubicin for Cancer Therapy 2021 ·Angewandte Chemie ·Lorena Simón‐Gracia, (unknown), (unknown), (unknown), (unknown), (unknown), Tambet Teesalu	2
8	Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis 2021 ·Nanomaterials ·Lorena Simón‐Gracia, (unknown), Vilma Petrikaitė, Allan Tobi, Merli Saare, Prakash Lingasamy, Maire Peters, Andres Salumets, Tambet Teesalu	13
9	Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide 2020 ·Molecular Pharmaceutics ·(unknown), Eliana K. Asciutto, Alessio Malfanti, Lorena Simón‐Gracia, (unknown), Marı́a J. Vicent, Tambet Teesalu, Pablo Scodeller	30
10	Peptide-guided nanoparticles for glioblastoma targeting 2019 ·Journal of Controlled Release ·Pille Säälik, Prakash Lingasamy, (unknown), (unknown), Liat Rousso-Noori, Allan Tobi, Lorena Simón‐Gracia, Hedi Hunt, Päärn Paiste, Venkata Ramana Kotamraju, Gabriele Bergers, Toomas Asser, Tõnu Rätsep, Erkki Ruoslahti, Rolf Bjerkvig, Dinorah Friedmann‐Morvinski, Tambet Teesalu	79
11	iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity 2019 ·Journal of Nanobiotechnology ·(unknown), Lorena Simón‐Gracia, Pablo Scodeller, María de los Ángeles Ramírez, (unknown), Galo J. A. A. Soler‐Illia, Marina Simian	24
12	Phage-Display-Derived Peptide Binds to Human CD206 and Modeling Reveals a New Binding Site on the Receptor 2019 ·The Journal of Physical Chemistry B ·Eliana K. Asciutto, Sergei Kopanchuk, (unknown), Lorena Simón‐Gracia, Carlos Alemán, Tambet Teesalu, Pablo Scodeller	20
13	Competition of charge-mediated and specific binding by peptide-tagged cationic liposome–DNA nanoparticles in vitro and in vivo 2018 ·Biomaterials ·Emily Wonder, Lorena Simón‐Gracia, Pablo Scodeller, Ramsey N. Majzoub, Venkata Ramana Kotamraju, Kai K. Ewert, Tambet Teesalu, Cyrus R. Safinya	70
14	Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide 2017 ·Scientific Reports ·Pablo Scodeller, Lorena Simón‐Gracia, Sergei Kopanchuk, Allan Tobi, Kalle Kilk, Pille Säälik, (unknown), Mario Leonardo Squadrito, Venkata Ramana Kotamraju, Ago Rinken, Michele De Palma, Erkki Ruoslahti, Tambet Teesalu	135
15	Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles 2017 ·Journal of Controlled Release ·Hedi Hunt, Lorena Simón‐Gracia, Allan Tobi, Venkata Ramana Kotamraju, Shweta Sharma, (unknown), Kazuki N. Sugahara, Erkki Ruoslahti, Tambet Teesalu	53
16	Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy 2016 ·Molecular Cancer Therapeutics ·Lorena Simón‐Gracia, Hedi Hunt, Pablo Scodeller, Jens Gaitzsch, Gary B. Braun, (unknown), Erkki Ruoslahti, Giuseppe Battaglia, Tambet Teesalu	63
17	iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes 2016 ·Biomaterials ·Lorena Simón‐Gracia, Hedi Hunt, Pablo Scodeller, Jens Gaitzsch, Venkata Ramana Kotamraju, Kazuki N. Sugahara, (unknown), Erkki Ruoslahti, Giuseppe Battaglia, Tambet Teesalu	118
18	Biocompatible, multifunctional, and well-defined OEG-based dendritic platforms for biomedical applications 2013 ·Organic & Biomolecular Chemistry ·Lorena Simón‐Gracia, Daniel Pulido, Chantal Sevrin, Christian Grandfils, Fernando Alberício, Míriam Royo	12
19	Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes 2013 ·Cancer Letters ·(unknown), Denis Cecchin, Lorena Simón‐Gracia, Nicholas J. Warren, Jeppe Madsen, Steven P. Armes, Andrew L. Lewis, Sheila MacNeil, Giuseppe Battaglia	78
20	Liposomes Containing NY-ESO-1/Tetanus Toxoid and Adjuvant Peptides Targeted to Human Dendritic Cells Via The Fc Receptor for Cancer Vaccines 2013 ·Nanomedicine ·Luis J. Cruz, Félix Rueda, Lorena Simón‐Gracia, Begoña Cordobilla, Fernando Alberício, Joan Carles Domingo	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact